FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth Platform.”
Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO) (formerly New Leaf Brands Inc.) is pleased to announce that it has signed a definitive share exchange agreement with Mindleap Health Inc. (“Mindleap”) for the acquisition of a 100% interest in MindLeap’s Digital Telehealth Platform focused on the emerging psychedelics industry.
Mydecine Innovation’s Group is a life sciences company focused on the development and commercialization of products and services that contribute to improving overall health and wellbeing. The company’s mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. Mydecine Innovations Group owns a group of trailblazing companies that are focused on helping millions of people live better lives and our portfolio includes:
- Cannabis & Fungi Based Products
- Mycology Research & Development
- Disruptive Technology
- Therapeutic Treatment Facilities
- Large-Scale Distribution
- Psychedelic-Derived Medicines
- For more information, please visit: Mydecine Innovations Group Inc.
For more corporate news on Mydecine Innovations Group Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.